A retrospective, observational study analysing role of Empagliflozin and Dulaglutide on metabolic and glycemia outcomes in patients with type 2 diabetes
Latest Information Update: 22 Jul 2020
At a glance
- Drugs Dulaglutide (Primary) ; Empagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 22 Jul 2020 New trial record
- 16 Jun 2020 Results presented at the 80th Annual Scientific Sessions of the American Diabetes Association